Enlicitide chloride is a macrocyclic peptide compound being investigated as an orally available inhibitor of PCSK9 for the management of hypercholesterolaemia. It is supplied as a pharmaceutical raw material for research and manufacturing purposes.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 2407527-16-4
(alphaS)-5,6,7,8-Tetrahydro-alpha-[[(tetrahydro-4-methyl-2H-pyran-4-yl)carbonyl]amino]-1,8-naphthyridine-2-nonanoic acid
active pharmaceutical ingredient
N-Benzyl albuterol
active pharmaceutical ingredient
7-Ketoabiraterone acetate
pharmaceutical impurity reference standard
FLUPENTIXOL DIHYDROCHLORIDE
Active pharmaceutical ingredient for schizophrenia
[6-[[(11S,17S,20S,23S,27S,39S,42S,63S,66R)-47-fluoro-20-[(1R)-1-hydroxyethyl]-17-[(4-methoxyphenyl)methyl]-11,63-dimethyl-10,16,19,22,30,40,58,61,64,67,70-undecaoxo-28-oxa-1,9,15,18,21,24,31,41,51,62,65,68-dodecazanonacyclo[37.18.11.23,6.124,42.133,37.144,51.011,15.023,27.045,50]triheptaconta-3(73),4,6(72),33,35,37(71),44(69),45(50),46,48-decaen-66-yl]methylamino]-6-oxohexyl]-trimethylazanium chloride
CLOLWQCFULXMAR-QQCDJELVSA-N
C[C@H]1C(=O)N[C@@H](C(=O)N[C@H]2CC3=CC(=CC=C3)CNC(=O)CO[C@H]4CCN5[C@@H]4C(=O)N[C@H](C(=O)N[C@H](C(=O)N6CCC[C@]6(C(=O)NCCC7=CC=C(CN(CCCCCCN8C=C(C[C@@H](C5=O)NC2=O)C9=C8C=CC(=C9)F)C(=O)CCC(=O)N1)C=C7)C)CC1=CC=C(C=C1)OC)[C@@H](C)O)CNC(=O)CCCCC[N+](C)(C)C.[Cl-]